NextCure, Inc. financial data

Symbol
NXTC on Nasdaq
Industry
Pharmaceutical Preparations
Location
9000 Virginia Manor Road, Suite 200, Beltsville, MD
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 888 % -52.9%
Debt-to-equity 19.5 % +86.8%
Return On Equity -68.4 % -45.4%
Return On Assets -57.2 % -34.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 28M shares +0.37%
Common Stock, Shares, Outstanding 28M shares +0.37%
Entity Public Float 43.6M USD -11.4%
Common Stock, Value, Issued 28K USD 0%
Weighted Average Number of Shares Outstanding, Basic 28M shares +0.46%
Weighted Average Number of Shares Outstanding, Diluted 28M shares +0.46%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 41.5M USD -13.4%
General and Administrative Expense 15.7M USD -20.2%
Operating Income (Loss) -59.7M USD +11.7%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -55.7M USD +11.3%
Earnings Per Share, Basic -1.99 USD/shares +11.6%
Earnings Per Share, Diluted -1.99 USD/shares +11.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 27.7M USD +112%
Assets, Current 71.8M USD -36.3%
Property, Plant and Equipment, Net 5.46M USD -39.6%
Operating Lease, Right-of-Use Asset 3.26M USD -25.8%
Other Assets, Noncurrent 332K USD -82.4%
Assets 80.9M USD -36.8%
Accounts Payable, Current 5.35M USD +130%
Employee-related Liabilities, Current 1.75M USD +76.7%
Liabilities, Current 9.57M USD +39.1%
Operating Lease, Liability, Noncurrent 5.15M USD -13.4%
Other Liabilities, Noncurrent 661K USD -15.8%
Liabilities 15.4M USD +13%
Accumulated Other Comprehensive Income (Loss), Net of Tax 4K USD
Retained Earnings (Accumulated Deficit) -380M USD -17.2%
Stockholders' Equity Attributable to Parent 65.5M USD -42.8%
Liabilities and Equity 80.9M USD -36.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -12.6M USD +14.7%
Net Cash Provided by (Used in) Financing Activities 1K USD
Net Cash Provided by (Used in) Investing Activities 17.9M USD -1.33%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 28M shares +0.37%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 5.28M USD +57.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 27.7M USD +112%
Interest Paid, Excluding Capitalized Interest, Operating Activities 19K USD -9.52%
Deferred Tax Assets, Valuation Allowance 115M USD +16.5%
Deferred Tax Assets, Gross 116M USD +16%
Operating Lease, Liability 5.95M USD -9.93%
Payments to Acquire Property, Plant, and Equipment 37K USD -85.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -55.4M USD +9.8%
Lessee, Operating Lease, Liability, to be Paid 7.26M USD -13.4%
Property, Plant and Equipment, Gross 28.6M USD -2.42%
Operating Lease, Liability, Current 796K USD +21.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.36M USD +11.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.21M USD +7.72%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.31M USD -26.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.4M USD +3.03%
Deferred Tax Assets, Operating Loss Carryforwards 63.6M USD +12.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.44M USD +3.01%
Operating Lease, Payments 1.03M USD +12.6%
Additional Paid in Capital 446M USD +1.48%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 1.06M USD -23%
Share-based Payment Arrangement, Expense 6.34M USD -22.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%